About EndoAxis
EndoAxis is a company based in Beverly Hills (United States) founded in 2020 by Microbiome Labs, Guy Citrin, and Tom Bayne. EndoAxis has raised $550 thousand across 2 funding rounds. EndoAxis offers products and services including AI Hormonal Diagnostics and Personalized Supplements. EndoAxis operates in a competitive market with competitors including Viome, Flore, Elo Health, Baze and Ombre, among others.
- Headquarter Beverly Hills, United States
- Founders Microbiome Labs, Guy Citrin, Tom Bayne
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Endoaxis Labs Llc
- Jurisdiction Bangalore North, Karnataka, India
-
Annual Revenue
$403.09 K (USD)19.31as on Mar 31, 2022
-
Net Profit
$26.11 K (USD)-14.87as on Mar 31, 2022
-
EBITDA
$31.2 K (USD)28.43as on Mar 31, 2022
-
Total Equity Funding
$550 K (USD)
in 2 rounds
-
Latest Funding Round
$250 K (USD), Seed
Aug 04, 2025
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of EndoAxis
EndoAxis offers a comprehensive portfolio of products and services, including AI Hormonal Diagnostics and Personalized Supplements.
AI platform for analyzing and interpreting hormone lab results accurately
Custom formulations based on lab data to support hormone balance effectively
Funding Insights of EndoAxis
EndoAxis has successfully raised a total of $550K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $250 thousand completed in August 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by EndoAxis
Investment portfolio details for EndoAxis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - EndoAxis
Detailed financials for EndoAxis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Endoaxis Comparisons
Peer comparison for EndoAxis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of EndoAxis
EndoAxis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Viome, Flore, Elo Health, Baze and Ombre, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Machine learning-based bioinformatics solutions for health insights are provided.
|
|
| Locked | Locked | Locked |
Customized probiotics for gut health are provided via stool analysis.
|
|
| Locked | Locked | Locked |
Personalized supplements are delivered based on biochemical analysis.
|
|
| Locked | Locked | Locked |
Personalized vitamin supplements are provided based on biochemical tests.
|
|
| Locked | Locked | Locked |
Microbiome-based personalized supplements are offered via gut testing kits.
|
|
| Locked | Locked | Locked |
Provider of personalized nutrition supplements
|
Detailed competitors of EndoAxis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Endoaxis
Complete news archive for EndoAxis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about EndoAxis
EndoAxis was founded in 2020 and raised its 1st funding round 4 years after it was founded.
EndoAxis is headquartered in Beverly Hills, United States. It is registered at Beverly Hills, California, United States.
EndoAxis is a funded company, having raised a total of $550K across 2 funding rounds to date.
Annual revenue of EndoAxis is $403.09K as on Mar 31, 2022.
EndoAxis was founded in 2020 and is headquartered in Beverly Hills, United States. Operations focus on the health and wellness sector, where lab tests for diagnosing hormone dysfunction are conducted. Personalised treatment plans, including suggested formulations, are generated based on individual patient profiles to support nutritional and lifestyle interventions. Services are tailored to improve health outcomes through targeted remedies.
EndoAxis's top competitors include Viome, Flore and Elo Health.
EndoAxis offers AI Hormonal Diagnostics and Personalized Supplements.